Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis

Hyperphosphatemia is common among patients with CKD stage 5D and is associated with morbidity and mortality. Current guidelines recommend lowering serum phosphate concentrations toward normal. Tenapanor is a minimally absorbed small molecule inhibitor of the sodium/hydrogen exchanger isoform 3 that...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Soc Nephrol
Hlavní autoři: Block, Geoffrey A., Rosenbaum, David P., Leonsson-Zachrisson, Maria, Åstrand, Magnus, Johansson, Susanne, Knutsson, Mikael, Langkilde, Anna Maria, Chertow, Glenn M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Nephrology 2017
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5461797/
https://ncbi.nlm.nih.gov/pubmed/28159782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016080855
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky